Patents by Inventor Mostafa S. Fahim

Mostafa S. Fahim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5372822
    Abstract: A method for chemically castrating male pigs in a manner that modulates the production of testosterone and interferes with the enzymatic conversion of testosterone into androstenone by injecting a mineral acetate solution into both testes or epididymides in an amount effective to reduce the pig's serum testosterone level below that of an intact male.
    Type: Grant
    Filed: March 7, 1994
    Date of Patent: December 13, 1994
    Inventor: Mostafa S. Fahim
  • Patent number: 5234698
    Abstract: A method of treating the prostate by intraprostatic injection of zinc ions in a concentration effective to increase the amount of prostatic antibacterial factor and to inhibit the rate of prostatic growth. The treatment is applied to patients with prostatitis, to patients with benign adenomatous hyperplasia of the prostate after prostatic resection and to patients with early prostatic carcinoma as an alternative to surgery as needed to provide long-term remission. The treatment is also applied prophylactically to prevent the development of prostatitis, particularly in males of advanced age.
    Type: Grant
    Filed: December 5, 1991
    Date of Patent: August 10, 1993
    Inventor: Mostafa S. Fahim
  • Patent number: 5071658
    Abstract: A method of treating the prostate by intraprostatic injection of zinc ions in a concentration effective to increase the amount of prostatic antibacterial factor and to inhibit the rate of prostatic growth. The treatment is applied to patients with prostatitis, to patients with benign adenomatous hyperplasia of the prostate after prostatic resection and to patients with early prostatic carcinoma as an alternative to surgery as needed to provide long-term remission. The treatment is also applied prophylactically to prevent the development of prostatitis, particularly in males of advanced age.
    Type: Grant
    Filed: July 23, 1990
    Date of Patent: December 10, 1991
    Inventor: Mostafa S. Fahim
  • Patent number: 5070080
    Abstract: A cell permeable physiologically acceptable water soluble mineral salt of a carboxylic acid such as zinc acetate, calcium acetate, zinc gluconate and the like having a pH in the range of 6.0 to 7.5 capable of forming a stable solution under ambient conditions at pH 7.0 is bioavailably effective at inhibiting the generation, maturation, motility and viability of sperm when applied to sperm or developing sperm in the testis, epididymis or vas deferens of a male subject or the vagina, cervix, uterus or fallopian tubes of a female subject. When the subject is a male subject and the mineral salt is zinc gluconate or the like and is injected into the testis or epididymis, the stability and efficacy of the mineral salt at pH 7.0 is improved by the presence of an amino acid such as arginine which acts as a permeation enhancer.
    Type: Grant
    Filed: January 30, 1989
    Date of Patent: December 3, 1991
    Inventor: Mostafa S. Fahim
  • Patent number: 4946688
    Abstract: A method of treating the prostate by intraprostatic injection of zinc ions in a concentration effective to increase the amount of prostatic antibacterial factor and to inhibit the rate of prostatic growth. The treatment is applied to patients with prostatitis, to patients with benign adenomatous hyperplasia of the prostate after prostatic resection and to patients which early prostatic carcinoma as an alternative to surgery as needed to provide long-term remission. The treatment is also applied prophylactically to prevent the development of prostatitis, particularly in males of advanced age.
    Type: Grant
    Filed: July 5, 1988
    Date of Patent: August 7, 1990
    Inventor: Mostafa S. Fahim
  • Patent number: 4937234
    Abstract: A soluble mineral in bioavailable form is formed from a mineral salt of a carboxylic acid derivative of a pentose or hexose such as zinc gluconate and an amino acid having the ability of stabilize the mineral salt when the mixture id neutralized in the zone of intracellular pH. Methods of treating an organism with the above-mentioned minerals are disclosed.
    Type: Grant
    Filed: August 10, 1988
    Date of Patent: June 26, 1990
    Inventor: Mostafa S. Fahim
  • Patent number: 4711780
    Abstract: A medication for treating the surface epithelium is disclosed comprising vitamin C, a zinc salt and a sulfur amino acid. In some cases, the medication may additionally contain a mucopolysaccharide and/or a polysaccharide. A method of stimulating cell proliferation and new cell formation with said medication is also disclosed.
    Type: Grant
    Filed: May 12, 1986
    Date of Patent: December 8, 1987
    Inventor: Mostafa S. Fahim
  • Patent number: 4372296
    Abstract: A composition is disclosed which when topically applied is effective in the treatment of acne and skin disorders. While the etiology of the treatment is complex, it is believed that the composition reduces the rate of sebum secretion, inhibits the formation of keratin and fatty acids in the pilosebaceous ducts and is antimicrobial to the bacteria normally found in said ducts. The treatment is accomplished quicker and stimulates the production of collagen in the healing of scars if the composition is sonicated into the affected area with ultrasonic vibrations.
    Type: Grant
    Filed: November 26, 1980
    Date of Patent: February 8, 1983
    Inventor: Mostafa S. Fahim
  • Patent number: 4357934
    Abstract: Male infertility is treated by increasing the concentration of testosterone in the seminiferous tubules by intratesticular injection of an aqueous suspension of testosterone and/or chorionic gonadotropins without correspondingly increasing the testosterone level in the blood plasma and thereby without substantially interfering with the secretion of the gonadotropins FSH and LH by the pituitary.
    Type: Grant
    Filed: July 23, 1980
    Date of Patent: November 9, 1982
    Assignee: The Curators of the University of Missouri
    Inventor: Mostafa S. Fahim
  • Patent number: 4339438
    Abstract: An injectable chemical compound capable of producing sterility in male animals having scrotal testes for use in selectively controlling the exocrine function of the testes in the production of sperm and the endocrine function in the production of testosterone. Said injectable chemical compound being a physiologically acceptable astringent, preferably a water soluble zinc compound, a tannin or combinations thereof. Various concentrations of said compound being selectively injected directly into the testes or into the scrotum to suppress spermatogenesis and, optionally, to suppress production of testosterone.
    Type: Grant
    Filed: May 25, 1979
    Date of Patent: July 13, 1982
    Assignee: The Curators of the University of Missouri
    Inventor: Mostafa S. Fahim
  • Patent number: 4309989
    Abstract: A method of topically applying an effective medication in an emulsion coupling agent by ultrasound. More particularly, a method of treating a skin condition by applying a medication in an emulsion coupling agent and massaging it into the affected area with ultrasonic vibrations thereby causing the medication to penetrate into the skin. Specifically, a method and composition for the treatment of Herpes Simplex Type 1 and Type 2 lesions. Also specifically, a method and composition for the treatment of demidox mites.
    Type: Grant
    Filed: August 14, 1978
    Date of Patent: January 12, 1982
    Assignee: The Curators of the University of Missouri
    Inventor: Mostafa S. Fahim
  • Patent number: 4229430
    Abstract: A therapeutic composition is disclosed for use in improving the physiological tone of the oral tissues, which among other beneficial effects nourishes said tissues and causes them to approach normal condition. The therapeutic composition also has an antimicrobial effect on the oral microflora including those difficult to eliminate pathogenic genera known to be implicated in dental caries and periodontal disease. The therapeutic composition comprises a pharmaceutically acceptable, water soluble zinc salt and ascorbic acid or an active analog thereof. The zinc salt and the ascorbic acid are present in an amount sufficient to provide a synergistic combination which has a greater than additive antimicrobial effect on such oral genera as Actinomyces, Streptococcus, Staphylococcus, Candida, Pseudomonas and Escherichia.
    Type: Grant
    Filed: August 21, 1978
    Date of Patent: October 21, 1980
    Inventors: Mostafa S. Fahim, Ercell L. Miller
  • Patent number: 4156427
    Abstract: An injectable chemical compound capable of producing sterility in male animals having scrotal testes for use in selectively controlling the exocrine function of the testes in the production of sperm and the endocrine function in the production of testosterone. Said injectable chemical compound being a physiologically acceptable astringent, preferably a water soluble zinc compound, a tannin or combinations thereof. Various concentrations of said compound being selectively injected directly into the testes or into the scrotum to suppress spermatogenesis and, optionally, to suppress production of testosterone.
    Type: Grant
    Filed: January 5, 1977
    Date of Patent: May 29, 1979
    Assignee: The Curators of the University of Missouri
    Inventor: Mostafa S. Fahim
  • Patent number: 4078556
    Abstract: Apparatus useful in suppressing spermatogenesis in human males by applying ultrasonic vibrations to the testes. More particularly, apparatus useful in suppressing spermatogenesis by sonicating male testes including a cup for immersing the testes in an ultrasonic coupling agent and an ultrasonic applicator for applying ultrasonic vibrations thereto.
    Type: Grant
    Filed: April 6, 1976
    Date of Patent: March 14, 1978
    Inventor: Mostafa S. Fahim
  • Patent number: 4077401
    Abstract: A method of suppressing spermatogenesis in human males by applying ultrasonic vibrations to the testes. More particularly, a method of suppressing spermatogenesis by sonicating male testes by immersing them in an ultrasonic coupling agent and applying ultrasonic vibrations thereto.
    Type: Grant
    Filed: April 6, 1976
    Date of Patent: March 7, 1978
    Inventor: Mostafa S. Fahim
  • Patent number: 4073289
    Abstract: A method of suppressing spermatogenesis in domestic mammals having a scrotum by applying ultrasonic vibrations to the testes in said scrotum. More particularly, a method of suppressing spermatogenesis by sonicating the testes in said scrotum by immersing the scrotum in an ultrasonic coupling agent and applying ultrasonic vibrations thereto.
    Type: Grant
    Filed: April 30, 1976
    Date of Patent: February 14, 1978
    Inventor: Mostafa S. Fahim